Comprehensive treatment of bronchial asthma in children using resistol

Аннотация

Studied 78 children with varying degrees of bronchial asthma severity at the clinic of Hospital, Outpatient and Emergency Therapy Department of Andijan State Medical Institute in Andijan, aged 6-14 years. For prospective study we have formed two groups of patients: the first group of patients who received standard baseline therapy and placebo tablet (n = 35); the second group of patients (n = 43), who received along with baseline therapy, received the drug "Resistol". Administration of this drug suppresses the metabolism of corticoid hormones in the body, and the duration of their action increases.